HomeCompareOCPNF vs EQR

OCPNF vs EQR: Dividend Comparison 2026

OCPNF yields 1.60% · EQR yields 4.73%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 OCPNF wins by $25.61M in total portfolio value· pulled ahead in Year 3
10 years
OCPNF
OCPNF
● Live price
1.60%
Share price
$9.33
Annual div
$0.15
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.65M
Annual income
$22,904,855.92
Full OCPNF calculator →
EQR
EQR
● Live price
4.73%
Share price
$58.58
Annual div
$2.77
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.5K
Annual income
$3,819.61
Full EQR calculator →

Portfolio growth — OCPNF vs EQR

📍 OCPNF pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOCPNFEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OCPNF + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
OCPNF pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OCPNF
Annual income on $10K today (after 15% tax)
$136.31/yr
After 10yr DRIP, annual income (after tax)
$19,469,127.53/yr
EQR
Annual income on $10K today (after 15% tax)
$401.93/yr
After 10yr DRIP, annual income (after tax)
$3,246.67/yr
At 15% tax rate, OCPNF beats the other by $19,465,880.86/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OCPNF + EQR for your $10,000?

OCPNF: 50%EQR: 50%
100% EQR50/50100% OCPNF
Portfolio after 10yr
$12.84M
Annual income
$11,454,337.76/yr
Blended yield
89.18%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

OCPNF
No analyst data
Altman Z
3.0
Piotroski
7/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+20.1% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OCPNF buys
0
EQR buys
0
No recent congressional trades found for OCPNF or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOCPNFEQR
Forward yield1.60%4.73%
Annual dividend / share$0.15$2.77
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%15.8%
Portfolio after 10y$25.65M$40.5K
Annual income after 10y$22,904,855.92$3,819.61
Total dividends collected$25.41M$16.9K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: OCPNF vs EQR ($10,000, DRIP)

YearOCPNF PortfolioOCPNF Income/yrEQR PortfolioEQR Income/yrGap
1$11,021$320.73$11,248$547.57$227.00EQR
2$12,453$660.69$12,701$666.53$248.00EQR
3← crossover$14,720$1,395.40$14,405$814.59+$315.00OCPNF
4$18,833$3,083.07$16,413$999.84+$2.4KOCPNF
5$27,525$7,373.14$18,795$1,232.92+$8.7KOCPNF
6$49,593$20,141.65$21,639$1,527.95+$28.0KOCPNF
7$120,897$67,832.60$25,057$1,903.80+$95.8KOCPNF
8$438,446$309,085.52$29,197$2,385.87+$409.2KOCPNF
9$2,564,328$2,095,191.15$34,250$3,008.70+$2.53MOCPNF
10$25,648,687$22,904,855.92$40,467$3,819.61+$25.61MOCPNF

OCPNF vs EQR: Complete Analysis 2026

OCPNFStock

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through four segments: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopes, endoscopy system, and repair services. The Therapeutic Solutions Business segment provides urology, gynecology, ear, nose, and throat products; endo-therapy and energy devices; and surgical single-use devices. The Scientific Solutions Business segment offers biological and industrial microscopes, industrial endoscopes and videoscopes, non-destructive testing equipment, and X-ray fluorescence (XRF) analyzers. The Others segment offers biomedical materials and orthopedic equipment. The company also offers medical devices, such as surgical microscopes, endoscope reprocessors, electrosurgical devices, and respiratory-endotherapy devices, as well as system integration and maintenance/services. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was founded in 1919 and is headquartered in Tokyo, Japan.

Full OCPNF Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this OCPNF vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OCPNF vs SCHDOCPNF vs JEPIOCPNF vs OOCPNF vs KOOCPNF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.